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Edited by Horst FeldmannAbstract The intranuclear disposition of exogenous DNA is
highly important for the therapeutic eﬀects of the administrated
DNA. Naked luciferase-plasmid DNA was delivered into mouse
liver by a hydrodynamics-based injection, and the amounts of
intranuclear plasmid DNA, luciferase, and its mRNA were quan-
titated at various time points. Methylation of the promoter of the
luciferase gene was also analyzed. Expression eﬃciency from
one copy of the exogenous DNA dramatically decreased over
time, and the DNA was methylated and degraded into fragments.
Unexpectedly, methylation of the intact plasmid DNA was low
and did not increase over time. Rather, the fragmented DNA
was methylated more frequently than the intact plasmid. These
results suggest that the CpG methylation and the degradation
of exogenous DNA, and its ‘silencing’, occurred in parallel in
the nucleus.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
Keywords: Exogenous DNA; Intranuclear disposition;
Silencing; Methylation; Fragmentation; Hydrodynamics-based
injection1. Introduction
Non-viral vectors using plasmid DNA are quite attractive in
gene therapy due to their excellent safety proﬁle, despite their
low transgene expression eﬃciency in comparison to viral vec-
tors [1–4]. The intracellular DNA traﬃcking, particularly the
entry into the nucleus, is a very important issue for high trans-
gene expression. Moreover, the intranuclear disposition, after
the nuclear DNA entry, is also a key factor for eﬃcient and
prolonged transgene expression [4]. For example, transgene
expression with non-viral vectors is generally transient [2]. This
would be a consequence of the degradation/excretion of the
exogenous DNA. Thus, the intranuclear disposition of the
exogenous DNA is of great interest.
Recently, the methylation status of the CMV promoter of an
adenoviral vector was examined [5]. The authors reported that
30% and 70% of CpG sites were methylated at days 1 and
7, respectively. They concluded that the methylation was the
major mechanism responsible for the decreased expression*Corresponding author. Fax: +81 11 706 4879.
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doi:10.1016/j.febslet.2006.01.017from adenoviral DNA. Likewise, CpG methylation may re-
duce transgene expression from plasmid DNA delivered by
non-viral vectors. Hong et al. suggested that the CpG dinucle-
otides may undergo de novo methylation in plasmid DNA in
mammalian cells [6]. Moreover, transgene expression was
reportedly enhanced when fewer CpG sequences were present
in the plasmid DNA [7], implying that CpG methylation sup-
pressed transgene expression.
In this study, we delivered naked luciferase-plasmid DNA
into mouse liver by a hydrodynamics-based injection, and
the intranuclear disposition of the plasmid DNA was exam-
ined. In addition, we analyzed the methylation status of the
promoter region of the intranuclear plasmid DNA. Our results
revealed the intranuclear disposition of exogenous DNA and
suggest that the methylation ratio of the intact plasmid
DNA was low and did not increase over time, excluding the
possibility that the CpG methylation triggered ‘silencing’.2. Materials and methods
2.1. Oligodeoxyribonucleotides
Oligodeoxyribonucleotides (ODNs) were purchased from Sigma
Genosys Japan (Ishikari, Japan) in puriﬁed forms.
2.2. Plasmid
The HindIII site of the pGL3-Control plasmid (Promega, Madison,
WI, USA), and the DraIII site of the pQBI25 plasmid (Takara, Kusa-
tsu, Japan) were converted to SacII and HindIII sites, respectively, by
ODN linker-mediated mutagenesis. The CMV promoter (BglII–SacII)
and the poly(A) sequence (XbaI–HindIII), and the luciferase gene frag-
ment (SacII–XbaI), derived from pQBI25 and pGL3-Control after the
conversions described above, respectively, were ligated to the back-
bone part (BglII–HindIII) of pQBI63 (Takara) to yield pYK-CMV-
luc (8.5 kb). This plasmid DNA, containing the CMV promoter and
the luciferase gene, was ampliﬁed in the Escherichia coli strain DH5a
and puriﬁed with a Qiagen (Hilden, Germany) EndoFree Plasmid
Mega kit. Endotoxin was removed by a treatment with Triton X-
114, as described previously [8]. Plasmids were checked for the absence
(<6.0 · 105 endotoxin units/lg DNA) of endotoxin with the LAL test
(Pyrogent kit, BioWhittacker, Walkersville, MD, USA). The absor-
bance at 260 nm and the Hoechst 33258 ﬂuorescence were measured
to quantify the DNA concentrations.2.3. Hydrodynamics-based injection
The pYK-CMV-luc plasmid (500 ng in 2 ml of saline) was injected
into the tail vein of female six-week-old Balb/c mice within 5 s [9,10].
The livers were harvested from the injected mice at various time points,
and the luciferase activity and the amount of the plasmid DNA were
measured as described below.blished by Elsevier B.V. All rights reserved.
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Livers were minced with scissors and homogenized completely in Ly-
sis Buﬀer (100 mM Tris–HCl, 2 mM EDTA, 0.1% Triton X-100, pH
7.8). After centrifugation at 13000 · g for 10 min at 4 C, the superna-
tant was examined for luciferase activity, using a Luciferase Assay Sys-
tems kit (Promega).
2.5. Isolation of nuclear DNA and quantitative PCR
Livers were homogenized in phosphate-buﬀered saline (PBS). After
centrifugation at 2500 · g for 5 min at 4 C, the pellet was washed
three times with PBS. The pellet was resuspended in DNA Lysis Buﬀer
(10 mM Tris–HCl, 10 mM NaCl, 3 mM MgCl2, 0.5% (w/v) IGEPAL-
CA630, pH 7.4) [11]. After centrifugation at 1400 · g for 5 min at 4 C,
the pellet was washed three times with DNA Lysis Buﬀer. The intranu-
clear DNA was extracted with SepaGene (Sanko Jun-yaku, Tokyo,
Japan).
Quantitative PCR (Q-PCR) was performed using an ABI 7700 se-
quence detection system and a 7500 real time PCR system, and
SYBR-Green chemistry. A 100 ng portion of the recovered DNA
was analyzed by Q-PCR. To detect the full-length luciferase plasmid
in the mouse liver, a lacZ plasmid was added as an internal standard
into the samples recovered from the mice. After digestion with PstI,
which cuts the luciferase and lacZ plasmid DNAs at unique sites,
and the ‘‘plasmid region’’ was puriﬁed by 1% low melting point aga-
rose gel electrophoresis. The plasmid region was determined by refer-
ence to the electrophoretic mobilities of marker DNAs in the same
gel, and this manipulation excluded the fragmented DNAs from the
DNA samples recovered from mice. The diﬀerence in the recovery ra-
tios in the gel puriﬁcation was corrected by the amounts of the lacZ
plasmid, which were also determined by Q-PCR. The luciferase gene
in the mouse liver was detected using the following primers: Luc (+),
5 0-GGTCCTATGATTATGTCCGGTTATG; Luc (), 5 0-ATG-
TAGCCATCCATCCTTGTCAAT. The lacZ plasmid added as an
internal standard was detected using the following primers: LacZ
(+), 5 0-GTTCTGTATGAACGGTCTGG; LacZ (), 5 0-TAT-
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Fig. 1. Expression of the luciferase gene, examined by hydrodynamics-
based injection of naked plasmid. The pYK-CMV-luc plasmid (500 ng)
was injected into the tail vein of female Balb/c mice (six weeks old), as
described in Section 2. The livers were harvested, and the luciferase
activities and amounts of the luciferase mRNA were measured. The
values represent the averages of at least three separate experiments.
Bars indicate S.D. (standard deviation). Closed circles, the luciferase
activity; open circles, the luciferase mRNA.2.6. Quantitative RT-PCR analysis of luciferase mRNA
Total RNA was extracted from mouse liver using an RNeasy Mini
Kit combined with RNase-free DNase Digest Set (Qiagen) for the deg-
radation of genomic DNA in total RNA samples. First-strand cDNA
synthesis was performed on 500 ng of total RNA using an oligo dT pri-
mer and an RNA PCR Kit (AMV) (Takara) as described by the man-
ufacture’s instructions. Each of the mRNA transcripts was quantitated
by Q-PCR method using Luc (+) and Luc () primers as described
above. Data were expressed as a ratio to the b-actin mRNA which
was determined using the following primers: b-actin (+), 5 0-AGA-
GGGAAATCGTGCGTGAC; b-actin (), 5 0-CAATAGTGAT-
GACCTGGCCGT.
2.7. DNA methylation analysis
The methylation status of the CMV promoter region was examined
by employing a combination of a methylation-sensitive restriction
enzyme and Q-PCR, using Taqman chemistry. The samples recovered
from the injected mice were digested with PstI, which cuts the plas-
mid DNA at a unique site outside the promoter region. After phe-
nol/chloroform extraction and ethanol precipitation, the DNA was
treated with BsaHI, which has a recognition site in the promoter
region. This restriction enzyme cleaves 50-G(A/G)C*G(C/T)C-3 0 se-
quences, but cannot cut the sequences where the C* residue is meth-
ylated. Thus, only the methylated DNA was ampliﬁed by Q-PCR
after the BsaHI digestion. To detect the DNA methylated in the
BsaHI site (promoter region) by Q-PCR, the following ODNs were
used: CMV pro (+), 5 0-GCGGAGTTGTTACGACATTTTG; CMV
pro (), 5 0-CGTGGATAGCGGTTTGACTCA; CMV pro (Taq-
man), 5 0-FAM-CTCCCATTGACGTCAAT-MGB. Total luciferase
DNA was also determined by Q-PCR using the Luc (+) and Luc
() primers described above, and there was no BsaHI site in this
ampliﬁed region. The methylation ratio was calculated by determin-
ing the amounts of methylated DNA relative to the total DNA.
Under our experimental conditions, the calculation by this procedure
provided reasonable methylation ratios when mixtures of unmethy-
lated and in vitro-methylated plasmid DNAs were tested (data not
shown).3. Results
3.1. Time courses of the luciferase activity and the amount of
intranuclear DNA
To examine the relationship between the amount of exoge-
nous DNA and the transgene expression, a rapid, high-volume
injection method (hydrodynamics-based administration) [9,10]
was used for delivery to the liver of female Balb/c mice (six
weeks old). This method enables the delivery of exogenous
DNA into the nuclei of the liver, without the aid of cationic
lipids and polymers, which could potentially aﬀect the quanti-
tation of the intranuclear exogenous DNA. The livers were
harvested after 4, 8, 24, 48, 72, 96, and 168 h, and the luciferase
activity was measured. The amounts of exogenous DNA at the
same time points were examined by quantitative polymerase
chain reaction (Q-PCR) after isolation of the nuclei.
As shown in Fig. 1, the luciferase activity peaked at 8 h post-
injection, and then decreased rapidly. The luciferase activity at
72 h was 73-fold less than that at 24 h. On the other hand, the
amount of exogenous DNA in the nuclei decreased gradually
(Fig. 2A). The amount of exogenous DNA at 72 h was 2.3-fold
less than that at 24 h. Thus, the decrease in the expression
(luciferase activity) was more than 32 times as rapid as the de-
crease in the amount of exogenous DNA. We also measured
luciferase expression at the transcript level and obtained results
similar to those at the protein level (Fig. 1). The luciferase
mRNA at 72 h was 115-fold less than that at 24 h. Since the
amount of exogenous DNA, determined by Q-PCR, might in-
clude fragmented DNA as well as the intact plasmid, we frac-
tionated the DNA recovered from the livers on a low melting
point agarose gel, and puriﬁed the ‘intact plasmid’ from the
gel. When these intact plasmid DNAs were analyzed by Q-
PCR, the amounts of the intact plasmid were lower that those
of the total exogenous DNA during the 4–72 h time span
(Fig. 3A). After 72 h, the amount of the total exogenous
DNA was almost identical to that of the intact plasmid. Thus,
DNA fragments derived from the plasmid DNA existed in the
nuclei within a 72-h time period. At 4 h after the administra-
tion, the intact plasmid represented one-ninth of the total
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Fig. 2. (A) Amounts of total luciferase DNA in the nucleus and (B)
expression eﬃciencies per single copy of DNA, based on the total
luciferase amounts. The pYK-CMV-luc plasmid (500 ng) was injected
into the tail vein of female Balb/c mice (six weeks old), and DNA was
extracted from the nuclei of the livers, as described in Section 2. (B)
The luciferase activities shown in Fig. 1 were divided by the DNA
amounts at the same time points. The values in panel A represent the
averages of at least three separate experiments. Bars indicate S.D.
(standard deviation).
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Fig. 3. (A) Amounts of intact luciferase plasmid in the nucleus and (B)
expression eﬃciencies per single copy of DNA, based on the amounts
of the intact plasmid. The intact plasmid was quantitated as described
in Section 2. (B) The luciferase activities shown in Fig. 1 were divided
by the DNA amounts at the same time points. The values in panel A
represent the averages of at least three separate experiments. Bars
indicate S.D. (standard deviation).
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intranuclear proteins with endo- and/or exonuclease activities
(see Section 4). The amount of the intact plasmid at 72 h
was only 1.2-fold less than that at 24 h.
The luciferase activities at various time points were divided
by the amounts of the exogenous DNAs at the same time
points (Figs. 2B and 3B). Since the luciferase protein might
be produced from the luc gene on the fragmented DNA, copy
numbers of the intact plasmid and the total exogenous DNA
(containing the luc gene) were both considered. As shown in
Fig. 2B, the ratio of the luciferase activity (amount of the en-
coded protein) to the amount of the total exogenous DNA
peaked at 24 h, and then rapidly decreased. At 72 and 168 h,
the ratios were 1/32 and 1/140, respectively, of that at 24 h.
If we assume that the luciferase protein was produced only
from the intact plasmid, then the ratio of the amount of the
luciferase protein to that of the intact plasmid DNA peaked
at 8 h (Fig. 3B). At 72 and 168 h, the ratios were 1/110 and
1/440, respectively, of that at 8 h. Thus, the expression from
the exogenous DNA was suppressed over time. When the ra-
tios of the amount of the luciferase mRNA to that of the
DNA were calculated, similar decrease in expression eﬃciency
was observed (data not shown). This ‘silencing’ event might be
derived from the methylation of the exogenous DNA.3.2. Methylation status of intranuclear DNA
It is well known that the methylation of CpG sequences,
especially those in promoter regions, suppresses transcription
[12–15]. Therefore, we examined the methylation status of
the intranuclear exogenous DNA. We calculated the methyla-
tion ratio by Q-PCR with a methylation-sensitive restriction
enzyme treatment. A BsaHI site (5 0-GACGTC-3 0) exists in
the CMV promoter region, and this enzyme cannot cleave a
methylated 5 0-G(A/G)C*G(C/T)C-3 0 sequence (C* represents
5-methylcytosine). Thus, the exogenous DNA methylated at
this site is resistant toBsaHI, and the promoter region can be
ampliﬁed in the PCR process.
Surprisingly, the ratios of DNA methylated in the promoter
region were higher at earlier time points than those at later
time points (Fig. 4A), although the ability of the exogenous
DNA to be expressed decreased over time. In addition, the
methylation status of the intact plasmid DNA was similar be-
tween 4 and 168 h (Fig. 4B). This implies that the fragmented
DNA was methylated more frequently than the intact plasmid.
Indeed, when we analyzed the DNA recovered from the ‘frag-
mented DNA region’ (higher electrophoretic mobility region)
in the agarose gel, the methylation ratio was higher as com-
pared to that of the intact plasmid (data not shown). Thus,
the methylation occurred in the fragmented DNA more fre-
quently than in the intact plasmid DNA. Similar results were
obtained for other regions of the plasmid DNA (data not
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Fig. 4. The ratio of the methylation in the promoter region in (A) the
total luciferase DNA, and (B) the intact luciferase plasmid. The values
represent the averages of at least three separate experiments. Bars
indicate S.D. (standard deviation).
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unmethylated intact plasmids, and the methylated and unme-
thylated DNA fragments, at various time points (Table 1).
The methylated DNA fragments were 35-, 19-, 9-, and 7-fold
more abundant than the methylated full-length plasmid at 4,
8, 24, and 48 h, respectively, after the administration. Taken
together, we concluded that the degraded DNA fraction con-
tained more methylation in the promoter region.4. Discussion
We studied the intranuclear fate of exogenous DNA in
mouse liver, by administering naked plasmid DNA. As ex-
pected, the transgene expression was transient and the total
amount of exogenous DNA in the nucleus decreased over time
(Figs. 1 and 2A). In addition, we found (1) fragmentation of
the plasmid DNA occurred in the nucleus, (2) methylation oc-Table 1
Calculated amounts of methylated and unmethylated, and intact and fragm
Time post-injection (h)
4 8 24
Intact plasmid
Methylated 6.3 · 103 3.8 · 103 1.6 · 1
Unmethylated 1.6 · 105 1.2 · 105 6.3 · 1
DNA fragment
Methylated 2.2 · 105 7.1 · 104 1.4 · 1
Unmethylated 1.0 · 106 5.5 · 105 6.9 · 1
aAmounts of DNA are calculated based on the data shown in Figs. 2 and 4curred preferentially in the fragmented DNA, rather than in
the intact plasmid, (3) the expression eﬃciency per single copy
of the exogenous DNA dramatically decreased over time
(silencing), and (4) this silencing occurred independently of
the methylation of the promoter region (Figs. 2–4). Since the
methylation of the plasmid in vitro did not enhance the frag-
mentation (data not shown), the methylation that occurred
in vivo was unlikely to trigger the degradation of the exoge-
nous DNA. These ﬁndings suggest that the silencing, methyla-
tion, and fragmentation proceeded in the nucleus in parallel.
Additionally, the exogenous DNA may be excreted from the
nucleus [16].
We assumed that the CpG methylation caused the sup-
pressed transgene expression, as suggested in the case of an
adenoviral vector [5]. However, at least in mouse liver, the
methylation did not increase, while the expression eﬃciency
decreased rapidly (Figs. 2–4). Thus, the transgene was silenced
by other mechanisms. One possibility is histone modiﬁcation.
It is known that histone (de)acetylation and methylation regu-
late gene expression [17–20]. The histones bound to the exog-
enous DNA might be modiﬁed, and this might silence the
transgene. In agreement with this interpretation, Yamano
et al. previously demonstrated that a histone deacetylase inhib-
itor enhanced transgene expression [21].
We observed that the exogenous DNA was fragmented in
the nucleus at early time points. This means that the delivered
DNA became a substrate for endonuclease(s) and, possibly,
exonuclease(s). Many intranuclear proteins involved in DNA
repair and replication reportedly contain such activities [22].
The exogenous DNA might be recognized as an ‘invader’.
An ‘intranuclear immunization’ mechanism which could dis-
criminate the exogenous DNA from the endogenous DNA
might be present and involved in the methylation observed
in the fragmented DNA. The avoidance of this possible intra-
nuclear immunization mechanism might become a key factor
for prolonged transgene expression.
We used the luciferase activity (luciferase amount) as an
indicator of transgene expression. As shown in Fig. 1, the lucif-
erase mRNA determined by real time RT-PCR and the lucif-
erase activity underwent similar changes. This would be due
to the short half-life of the luciferase protein (3 h in mamma-
lian cells) [23–25].
Previously, Herweijer et al. measured amounts of plasmid
DNA and transgene expression after intraportal delivery of
DNA to liver [26]. Their results that the expression decreases
more rapidly than DNA is consistent with one of our ﬁndings,
although we also focused on earlier time points than they did.
In this study, we analyzed methylation of promoter and foundented DNAsa
48 72 168
03 9.6 · 102 1.9 · 103 1.3 · 103
04 3.8 · 104 5.1 · 104 2.3 · 104
04 6.4 · 103 5.1 · 102 0
04 4.9 · 104 1.1 · 104 8.9 · 103
. Values are expressed as copies/lg DNA.
922 H. Ochiai et al. / FEBS Letters 580 (2006) 918–922that the methylation occurred in fragmented DNA rather than
intact plasmid for the ﬁrst time. Additionally, we showed that
the methylation was not a key factor for the silencing of
transgene.
In this study, we observed the silencing, methylation, and
fragmentation of exogenous DNA delivered by a hydrody-
namics-based method. The intranuclear fate of the exogenous
DNA should be examined in more detail, and both the DNA
and carrier molecules should be designed and modiﬁed to con-
trol the intranuclear disposition.
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